Literature DB >> 28185117

A lesson from a reported pathogenic variant in Peutz-Jeghers syndrome: a case report.

Hu Tan1, Xianda Wei1, Pu Yang1, Yanru Huang1, Haoxian Li1, Desheng Liang1,2, Lingqian Wu3,4.   

Abstract

Peutz-Jeghers syndrome (PJS) is a rare autosomal dominant disorder characterized by mucocutaneous hyperpigmentation, gastrointestinal (GI) hamartmatous polyps, and an increased risk of various malignancies. Pathogenic variants in the LKB1 tumor suppressor gene (also known as STK11) are the major cause of PJS. In this study, compound heterozygous variants of LKB1, c.890G > A/ c.1062C > G and del(exon1)/ c.1062C > G, were identified in two sporadic Chinese PJS cases respectively. Although all these three variants had been related to the autosomal dominant PJS in previous studies, all evidences collected in this study including de novo data, segregation data, population data, in-silico data, and functional data indicated that del(exon1) and c.890G > A are pathogenic in these two PJS families rather than c.1062C > G. This finding would contribute to genetic counseling for individuals carrying the variant c.1062C > G with or without PJS phenotypes. Moreover, this finding reminds genetic counselors that it is necessary to reevaluate the pathogenicity of reported variants in a known Mendelian disorder in order to avoid a misleading decision.

Entities:  

Keywords:  Genetic counseling; LKB1; Pathogenicity; Peutz-Jeghers syndrome; Variant

Mesh:

Substances:

Year:  2017        PMID: 28185117     DOI: 10.1007/s10689-016-9963-8

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  16 in total

Review 1.  Peutz-Jeghers syndrome and management recommendations.

Authors:  Francis M Giardiello; Jill D Trimbath
Journal:  Clin Gastroenterol Hepatol       Date:  2006-04       Impact factor: 11.382

2.  Peutz-Jeghers syndrome: a systematic review and recommendations for management.

Authors:  A D Beggs; A R Latchford; H F A Vasen; G Moslein; A Alonso; S Aretz; L Bertario; I Blanco; S Bülow; J Burn; G Capella; C Colas; W Friedl; P Møller; F J Hes; H Järvinen; J-P Mecklin; F M Nagengast; Y Parc; R K S Phillips; W Hyer; M Ponz de Leon; L Renkonen-Sinisalo; J R Sampson; A Stormorken; S Tejpar; H J W Thomas; J T Wijnen; S K Clark; S V Hodgson
Journal:  Gut       Date:  2010-07       Impact factor: 23.059

3.  Novel mutations in the LKB1/STK11 gene in Dutch Peutz-Jeghers families.

Authors:  A M Westerman; M M Entius; P P Boor; R Koole; E de Baar; G J Offerhaus; J Lubinski; D Lindhout; D J Halley; F W de Rooij; J H Wilson
Journal:  Hum Mutat       Date:  1999       Impact factor: 4.878

4.  Gastrointestinal hamartomatous polyposis in Lkb1 heterozygous knockout mice.

Authors:  Hiroyuki Miyoshi; Masayuki Nakau; Tomo-o Ishikawa; Michael F Seldin; Masanobu Oshima; Makoto M Taketo
Journal:  Cancer Res       Date:  2002-04-15       Impact factor: 12.701

5.  Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase.

Authors:  D E Jenne; H Reimann; J Nezu; W Friedel; S Loff; R Jeschke; O Müller; W Back; M Zimmer
Journal:  Nat Genet       Date:  1998-01       Impact factor: 38.330

6.  Loss of LKB1 kinase activity in Peutz-Jeghers syndrome, and evidence for allelic and locus heterogeneity.

Authors:  H Mehenni; C Gehrig; J Nezu; A Oku; M Shimane; C Rossier; N Guex; J L Blouin; H S Scott; S E Antonarakis
Journal:  Am J Hum Genet       Date:  1998-12       Impact factor: 11.025

7.  Truncating mutations in Peutz-Jeghers syndrome are associated with more polyps, surgical interventions and cancers.

Authors:  Heidi Salloch; Anke Reinacher-Schick; Karsten Schulmann; Christian Pox; Jörg Willert; Andrea Tannapfel; Stefan Heringlake; Timm O Goecke; Stefan Aretz; Susanne Stemmler; Wolff Schmiegel
Journal:  Int J Colorectal Dis       Date:  2009-09-02       Impact factor: 2.571

8.  LKB1 haploinsufficiency cooperates with Kras to promote pancreatic cancer through suppression of p21-dependent growth arrest.

Authors:  Jennifer P Morton; Nigel B Jamieson; Saadia A Karim; Dimitris Athineos; Rachel A Ridgway; Colin Nixon; Colin J McKay; Ross Carter; Valerie G Brunton; Margaret C Frame; Alan Ashworth; Karin A Oien; T R Jeffry Evans; Owen J Sansom
Journal:  Gastroenterology       Date:  2010-05-06       Impact factor: 22.682

9.  Characterization of the STK11 splicing variant as a normal splicing isomer in a patient with Peutz-Jeghers syndrome harboring genomic deletion of the STK11 gene.

Authors:  Kenta Masuda; Yusuke Kobayashi; Tokuhiro Kimura; Kiyoko Umene; Kumiko Misu; Hiroyuki Nomura; Akira Hirasawa; Kouji Banno; Kenjiro Kosaki; Daisuke Aoki; Kokichi Sugano
Journal:  Hum Genome Var       Date:  2016-03-03

10.  Structure of the LKB1-STRAD-MO25 complex reveals an allosteric mechanism of kinase activation.

Authors:  Elton Zeqiraj; Beatrice Maria Filippi; Maria Deak; Dario R Alessi; Daan M F van Aalten
Journal:  Science       Date:  2009-11-05       Impact factor: 47.728

View more
  1 in total

1.  The altered activity of P53 signaling pathway by STK11 gene mutations and its cancer phenotype in Peutz-Jeghers syndrome.

Authors:  Yu-Liang Jiang; Zi-Ye Zhao; Bai-Rong Li; Fu Yang; Jing Li; Xiao-Wei Jin; Hao Wang; En-Da Yu; Shu-Han Sun; Shou-Bin Ning
Journal:  BMC Med Genet       Date:  2018-08-09       Impact factor: 2.103

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.